We are live on
!
Find out more
KBC Group Portfolio holdings
AUM
$46.3B
1-Year Est. Return
43.9%
This Fund
S&P 500
This Quarter
Est. Return
+24.09%
1 Year Est. Return
+43.9%
3 Year Est. Return
+135.96%
5 Year Est. Return
+174.68%
10 Year Est. Return
+648.16%
AUM
$30.1B
AUM Growth
+$18.1B
(+152%)
Cap. Flow
+$14.4B
Cap. Flow
% of AUM
47.94%
Top 10 Holdings %
Top 10 Hldgs %
24.14%
Holding
1,348
New
61
Increased
986
Reduced
178
Closed
82
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$819M |
| 2 |
Apple
AAPL
|
+$774M |
| 3 |
Amazon
AMZN
|
+$413M |
| 4 |
Alibaba
BABA
|
+$291M |
| 5 |
UnitedHealth
UNH
|
+$263M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$80.3M |
| 2 |
AutoZone
AZO
|
+$19.9M |
| 3 |
NRG Energy
NRG
|
+$19.1M |
| 4 |
PARA
Paramount Global Class B
PARA
|
+$12.3M |
| 5 |
Capital One
COF
|
+$11.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.44% |
| 2 | Healthcare | 18.82% |
| 3 | Financials | 12.15% |
| 4 | Consumer Discretionary | 11.28% |
| 5 | Communication Services | 8.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1126
CRISPR Therapeutics
CRSP
$4.99B
| $176K | ﹤0.01% |
2,400
+1,200
| +100% | +$70.2K |
|
1127
Vanda Pharmaceuticals
VNDA
$308M
| $176K | ﹤0.01% |
+15,452
| New | +$175K |
|
1128
Sabre
SABR
$886M
| $174K | ﹤0.01% |
21,490
+7,986
| +59% | +$56.6K |
|
1129
Hanover Insurance
THG
$8.06B
| $174K | ﹤0.01% |
+1,722
| New | +$169K |
|
1130
AGCO
AGCO
$7.12B
| $172K | ﹤0.01% |
3,092
-949
| -23% | -$49.5K |
|
1131
Manhattan Associates
MANH
$11.1B
| $166K | ﹤0.01% |
1,752
-28,509
| -94% | -$2.12M |
|
|
CLGX
1132
DELISTED
Corelogic, Inc.
CLGX
| $166K | ﹤0.01% |
2,462
-30,778
| -93% | -$1.37M |
|
1133
Krystal Biotech
KRYS
$9.55B
| $164K | ﹤0.01% |
3,950
+3,575
| +953% | +$172K |
|
|
FFG
1134
DELISTED
FBL Financial Group
FFG
| $164K | ﹤0.01% |
+4,552
| New | +$167K |
|
1135
Acco Brands
ACCO
$407M
| $162K | ﹤0.01% |
22,818
+11,409
| +100% | +$71K |
|
1136
TIM SA
TIMB
$8.85B
| $160K | ﹤0.01% |
12,298
+6,149
| +100% | +$76.7K |
|
|
EIGR
1137
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $160K | ﹤0.01% |
553
+330
| +148% | +$97.3K |
|
1138
Kura Oncology
KURA
$824M
| $158K | ﹤0.01% |
9,700
+4,850
| +100% | +$70K |
|
1139
Zumiez
ZUMZ
$332M
| $156K | ﹤0.01% |
5,676
+2,838
| +100% | +$64.5K |
|
|
CSGS
1140
DELISTED
CSG Systems International
CSGS
| $154K | ﹤0.01% |
3,708
+838
| +29% | +$38.4K |
|
1141
Sonic Automotive
SAH
$2.68B
| $150K | ﹤0.01% |
4,708
+2,354
| +100% | +$54.2K |
|
1142
Avis
CAR
$4.89B
| $144K | ﹤0.01% |
6,316
-53,985
| -90% | -$991K |
|
1143
Genesco
GCO
$428M
| $144K | ﹤0.01% |
+6,610
| New | +$122K |
|
|
ITCL
1144
DELISTED
Banco Itau Chile American Depositary Shares (each representing one third of one (1/3) Common Share)
ITCL
| $144K | ﹤0.01% |
37,354
+18,677
| +100% | +$75.2K |
|
1145
AMERISAFE
AMSF
$551M
| $140K | ﹤0.01% |
2,276
+1,138
| +100% | +$70.8K |
|
1146
Scansource
SCSC
$1.16B
| $140K | ﹤0.01% |
5,842
+2,921
| +100% | +$69.1K |
|
1147
Builders FirstSource
BLDR
$7.8B
| $138K | ﹤0.01% |
6,640
+3,320
| +100% | +$60K |
|
1148
St. Joe Company
JOE
$3.84B
| $136K | ﹤0.01% |
7,028
+3,514
| +100% | +$64.7K |
|
1149
Coty
COTY
$2.39B
| $134K | ﹤0.01% |
30,026
-88,398
| -75% | -$429K |
|
1150
Emergent Biosolutions
EBS
$274M
| $134K | ﹤0.01% |
1,686
+843
| +100% | +$62.8K |
|
Similar funds
LP
TI
KBC Group's Q2 2020 Portfolio in Review
As of Q2 2020, KBC Group held 1,348 positions worth $30.1B, up 152% from $11.9B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
KBC Group deployed $14.4B of net new capital in Q2 2020, opening 61 new positions and adding to 986 existing holdings. Its largest new stake was Trade Desk: 422,440 shares worth $17.2M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was AutoZone, an estimated $19.9M trimmed.
- KBC Group's largest Q2 2020 buy was Trade Desk: 422,440 shares worth $17.2M.
- KBC Group added most to Microsoft in Q2 2020, an estimated $819M increase.
- KBC Group's biggest Q2 2020 reduction was AutoZone, cutting an estimated $19.9M.
- KBC Group fully exited Allergan plc in Q2 2020, selling an estimated $80.3M.
- KBC Group's ten largest holdings make up 24% of its $30.1B portfolio in Q2 2020.
- KBC Group opened 61 new positions and closed 82 in Q2 2020.
- KBC Group's portfolio value rose 152% quarter-over-quarter to $30.1B.
Based on KBC Group's 13F filing for Q2 2020, filed 10 Aug 2020.